{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:55:43Z","timestamp":1792518943414,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2012,2,29]],"date-time":"2012-02-29T00:00:00Z","timestamp":1330473600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1007\/s11064-012-0724-2","type":"journal-article","created":{"date-parts":[[2012,2,28]],"date-time":"2012-02-28T08:19:45Z","timestamp":1330417185000},"page":"1409-1419","source":"Crossref","is-referenced-by-count":84,"title":["Downregulating the Canonical Wnt\/\u03b2-catenin Signaling Pathway Attenuates the Susceptibility to Autism-like Phenotypes by Decreasing Oxidative Stress"],"prefix":"10.1007","volume":"37","author":[{"given":"Yinghua","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwen","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,2,29]]},"reference":[{"key":"724_CR1","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nrn1665","volume":"6","author":"L Ciani","year":"2005","unstructured":"Ciani L, Salinas PC (2005) WNTs in the vertebrate nervous system: from patterning to neuronal connectivity. Nat Rev Neurosci 6:351\u2013362","journal-title":"Nat Rev Neurosci"},{"key":"724_CR2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1126\/science.1074192","volume":"297","author":"A Chenn","year":"2002","unstructured":"Chenn A, Walsh CA (2002) Regulation of cerebral cortical size by control of cell cycle exit in neural precursors. Science 297:365\u2013369","journal-title":"Science"},{"key":"724_CR3","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1242\/dev.128.8.1253","volume":"128","author":"V Brault","year":"2001","unstructured":"Brault V, Moore R, Kutsch S et al (2001) Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development. Development 128:1253\u20131264","journal-title":"Development"},{"key":"724_CR4","doi-asserted-by":"crossref","unstructured":"Atkin TA, MacAskill AF, Brandon NJ et al. (2011) Disrupted in Schizophrenia-1 regulates intracellular trafficking of mitochondria in neurons. Mol Psychiatry 16:122\u2013124, 121","DOI":"10.1038\/mp.2010.110"},{"key":"724_CR5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ijdevneu.2010.08.007","volume":"29","author":"HB Clay","year":"2011","unstructured":"Clay HB, Sillivan S, Konradi C (2011) Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. Int J Dev Neurosci 29:311\u2013324","journal-title":"Int J Dev Neurosci"},{"key":"724_CR6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2165\/00023210-200115040-00004","volume":"15","author":"JK Yao","year":"2001","unstructured":"Yao JK, Reddy RD, van DKP (2001) Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications. CNS Drugs 15:287\u2013310","journal-title":"CNS Drugs"},{"key":"724_CR7","doi-asserted-by":"crossref","unstructured":"Crespi B, Stead P, Elliot M (2010) Evolution in health and medicine Sackler colloquium: comparative genomics of autism and schizophrenia. Proc Natl Acad Sci USA 107(Suppl 1):1736\u20131741","DOI":"10.1073\/pnas.0906080106"},{"key":"724_CR8","unstructured":"McGinnis WR (2004) Oxidative stress in autism. Altern Ther Health Med 10:22\u201336; quiz 37, 92"},{"key":"724_CR9","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1016\/j.lfs.2004.04.038","volume":"75","author":"A Chauhan","year":"2004","unstructured":"Chauhan A, Chauhan V, Brown WT et al (2004) Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin\u2014the antioxidant proteins. Life Sci 75:2539\u20132549","journal-title":"Life Sci"},{"key":"724_CR10","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1093\/ajcn\/80.6.1611","volume":"80","author":"SJ James","year":"2004","unstructured":"James SJ, Cutler P, Melnyk S et al (2004) Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr 80:1611\u20131617","journal-title":"Am J Clin Nutr"},{"key":"724_CR11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s12311-010-0223-4","volume":"10","author":"EM Sajdel-Sulkowska","year":"2010","unstructured":"Sajdel-Sulkowska EM, Xu M, McGinnis W et al (2010) Brain region-specific changes in oxidative stress and neurotrophin levels in autism spectrum disorders (ASD). Cerebellum 10:43\u201348","journal-title":"Cerebellum"},{"key":"724_CR12","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.1002\/anie.200902981","volume":"48","author":"HJ Lee","year":"2009","unstructured":"Lee HJ, Wang NX, Shi DL et al (2009) Sulindac inhibits canonical Wnt signaling by blocking the PDZ domain of the protein Dishevelled. Angew Chem Int Ed Engl 48:6448\u20136452","journal-title":"Angew Chem Int Ed Engl"},{"key":"724_CR13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1593\/neo.101172","volume":"13","author":"U Stein","year":"2011","unstructured":"Stein U, Arlt F, Smith J et al (2011) Intervening in beta-catenin signaling by sulindac inhibits S100A4-dependent colon cancer metastasis. Neoplasia 13:131\u2013144","journal-title":"Neoplasia"},{"key":"724_CR14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejphar.2008.10.053","volume":"602","author":"W Lu","year":"2009","unstructured":"Lu W, Tinsley HN, Keeton A et al (2009) Suppression of Wnt\/beta-catenin signaling inhibits prostate cancer cell proliferation. Eur J Pharmacol 602:8\u201314","journal-title":"Eur J Pharmacol"},{"key":"724_CR15","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1089\/thy.2009.0415","volume":"20","author":"NL Cho","year":"2010","unstructured":"Cho NL, Lin CI, Whang EE et al (2010) Sulindac reverses aberrant expression and localization of beta-catenin in papillary thyroid cancer cells with the BRAFV600E mutation. Thyroid 20:615\u2013622","journal-title":"Thyroid"},{"key":"724_CR16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s12311-010-0223-4","volume":"10","author":"EM Sajdel-Sulkowska","year":"2011","unstructured":"Sajdel-Sulkowska EM, Xu M, McGinnis W et al (2011) Brain region-specific changes in oxidative stress and neurotrophin levels in autism spectrum disorders (ASD). Cerebellum 10:43\u201348","journal-title":"Cerebellum"},{"key":"724_CR17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/mp.2008.63","volume":"15","author":"L Palmieri","year":"2010","unstructured":"Palmieri L, Papaleo V, Porcelli V et al (2010) Altered calcium homeostasis in autism-spectrum disorders: evidence from biochemical and genetic studies of the mitochondrial aspartate\/glutamate carrier AGC1. Mol Psychiatry 15:38\u201352","journal-title":"Mol Psychiatry"},{"key":"724_CR18","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1096\/fj.08-128926","volume":"23","author":"SJ James","year":"2009","unstructured":"James SJ, Rose S, Melnyk S et al (2009) Cellular and mitochondrial glutathione redox imbalance in lymphoblastoid cells derived from children with autism. FASEB J 23:2374\u20132383","journal-title":"FASEB J"},{"issue":"11","key":"724_CR19","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/ar.21232","volume":"293","author":"Z Wang","year":"2010","unstructured":"Wang Z, Xu L, Zhu X et al (2010) Demethylation of specific Wnt\/beta-catenin pathway genes and its upregulation in rat brain induced by prenatal valproate exposure. Anat Rec (Hoboken) 293(11):1947\u20131953","journal-title":"Anat Rec (Hoboken)"},{"key":"724_CR20","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1371\/journal.pone.0000093","volume":"1","author":"H Lemjabbar-Alaoui","year":"2006","unstructured":"Lemjabbar-Alaoui H, Dasari V, Sidhu SS et al (2006) Wnt and Hedgehog are critical mediators of cigarette smoke-induced lung cancer. PLoS One 1:e93","journal-title":"PLoS One"},{"key":"724_CR21","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1002\/ijc.25569","volume":"128","author":"Y Huang","year":"2011","unstructured":"Huang Y, Chang X, Lee J et al (2011) Cigarette smoke induces promoter methylation of single-stranded DNA-binding protein 2 in human esophageal squamous cell carcinoma. Int J Cancer 128:2261\u20132273","journal-title":"Int J Cancer"},{"key":"724_CR22","first-page":"885","volume":"2","author":"PL Rice","year":"2003","unstructured":"Rice PL, Kelloff J, Sullivan H et al (2003) Sulindac metabolites induce caspase- and proteasome-dependent degradation of beta-catenin protein in human colon cancer cells. Mol Cancer Ther 2:885\u2013892","journal-title":"Mol Cancer Ther"},{"key":"724_CR23","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/carcin\/24.2.263","volume":"24","author":"GA Orner","year":"2003","unstructured":"Orner GA, Dashwood WM, Blum CA et al (2003) Suppression of tumorigenesis in the Apc(min) mouse: down-regulation of beta-catenin signaling by a combination of tea plus sulindac. Carcinogenesis 24:263\u2013267","journal-title":"Carcinogenesis"},{"key":"724_CR24","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.pneurobio.2008.08.001","volume":"86","author":"EM Toledo","year":"2008","unstructured":"Toledo EM, Colombres M, Inestrosa NC (2008) Wnt signaling in neuroprotection and stem cell differentiation. Prog Neurobiol 86:281\u2013296","journal-title":"Prog Neurobiol"},{"key":"724_CR25","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.npp.1300518","volume":"30","author":"T Schneider","year":"2005","unstructured":"Schneider T, Przewlocki R (2005) Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Neuropsychopharmacology 30:80\u201389","journal-title":"Neuropsychopharmacology"},{"key":"724_CR26","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/sj.npp.1300767","volume":"31","author":"T Schneider","year":"2006","unstructured":"Schneider T, Turczak J, Przewlocki R (2006) Environmental enrichment reverses behavioral alterations in rats prenatally exposed to valproic acid: issues for a therapeutic approach in autism. Neuropsychopharmacology 31:36\u201346","journal-title":"Neuropsychopharmacology"},{"key":"724_CR27","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1126\/science.294.5540.34","volume":"294","author":"E Stokstad","year":"2001","unstructured":"Stokstad E (2001) Development. New hints into the biological basis of autism. Science 294:34\u201337","journal-title":"Science"},{"key":"724_CR28","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1542\/peds.2009-1522","volume":"124","author":"MD Kogan","year":"2009","unstructured":"Kogan MD, Blumberg SJ, Schieve LA et al (2009) Prevalence of parent-reported diagnosis of autism spectrum disorder among children in the US, 2007. Pediatrics 124:1395\u20131403","journal-title":"Pediatrics"},{"key":"724_CR29","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1542\/peds.2005-1516","volume":"117","author":"PT Shattuck","year":"2006","unstructured":"Shattuck PT (2006) The contribution of diagnostic substitution to the growing administrative prevalence of autism in US special education. Pediatrics 117:1028\u20131037","journal-title":"Pediatrics"},{"key":"724_CR30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1023\/A:1015453830880","volume":"32","author":"LA Croen","year":"2002","unstructured":"Croen LA, Grether JK, Hoogstrate J et al (2002) The changing prevalence of autism in California. J Autism Dev Disord 32:207\u2013215","journal-title":"J Autism Dev Disord"},{"key":"724_CR31","doi-asserted-by":"crossref","unstructured":"Blaxill MF, Baskin DS, Spitzer WO (2003) Commentary: Blaxill, Baskin, and Spitzer on Croen et al. (2002), the changing prevalence of autism in California. J Autism Dev Disord 33:223\u2013226; discussion 227\u2013229","DOI":"10.1023\/A:1022912115365"},{"key":"724_CR32","doi-asserted-by":"crossref","first-page":"6897","DOI":"10.1523\/JNEUROSCI.1712-06.2006","volume":"26","author":"E DiCicco-Bloom","year":"2006","unstructured":"DiCicco-Bloom E, Lord C, Zwaigenbaum L et al (2006) The developmental neurobiology of autism spectrum disorder. J Neurosci 26:6897\u20136906","journal-title":"J Neurosci"},{"key":"724_CR33","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/MOP.0b013e328336eb9a","volume":"22","author":"PJ Landrigan","year":"2010","unstructured":"Landrigan PJ (2010) What causes autism? Exploring the environmental contribution. Curr Opin Pediatr 22:219\u2013225","journal-title":"Curr Opin Pediatr"},{"key":"724_CR34","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1212\/WNL.0b013e3181af0b95","volume":"73","author":"ML Evatt","year":"2009","unstructured":"Evatt ML, DeLong MR, Grant WB et al (2009) Autism spectrum disorders following in utero exposure to antiepileptic drugs. Neurology 73:997","journal-title":"Neurology"},{"key":"724_CR35","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1212\/01.wnl.0000339399.64213.1a","volume":"71","author":"RL Bromley","year":"2008","unstructured":"Bromley RL, Mawer G, Clayton-Smith J et al (2008) Autism spectrum disorders following in utero exposure to antiepileptic drugs. Neurology 71:1923\u20131924","journal-title":"Neurology"},{"key":"724_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.reprotox.2009.02.014","volume":"28","author":"A Ornoy","year":"2009","unstructured":"Ornoy A (2009) Valproic acid in pregnancy: how much are we endangering the embryo and fetus. Reprod Toxicol 28:1\u201310","journal-title":"Reprod Toxicol"},{"key":"724_CR37","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.brainres.2011.06.015","volume":"1408","author":"V Bambini-Junior","year":"2011","unstructured":"Bambini-Junior V, Rodrigues L, Behr GA et al (2011) Animal model of autism induced by prenatal exposure to valproate: behavioral changes and liver parameters. Brain Res 1408:8\u201316","journal-title":"Brain Res"},{"key":"724_CR38","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1017\/S0012162205001076","volume":"47","author":"AD Rasalam","year":"2005","unstructured":"Rasalam AD, Hailey H, Williams JH et al (2005) Characteristics of fetal anticonvulsant syndrome associated autistic disorder. Dev Med Child Neurol 47:551\u2013555","journal-title":"Dev Med Child Neurol"},{"key":"724_CR39","doi-asserted-by":"crossref","first-page":"7545","DOI":"10.1038\/sj.onc.1210064","volume":"25","author":"GV Ferrari De","year":"2006","unstructured":"De Ferrari GV, Moon RT (2006) The ups and downs of Wnt signaling in prevalent neurological disorders. Oncogene 25:7545\u20137553","journal-title":"Oncogene"},{"key":"724_CR40","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.bbrc.2008.12.172","volume":"379","author":"A Zhang","year":"2009","unstructured":"Zhang A, Shen CH, Ma SY et al (2009) Altered expression of autism-associated genes in the brain of fragile X mouse model. Biochem Biophys Res Commun 379:920\u2013923","journal-title":"Biochem Biophys Res Commun"},{"key":"724_CR41","doi-asserted-by":"crossref","first-page":"e9706","DOI":"10.1371\/journal.pone.0009706","volume":"5","author":"MA Mines","year":"2010","unstructured":"Mines MA, Yuskaitis CJ, King MK et al (2010) GSK3 influences social preference and anxiety-related behaviors during social interaction in a mouse model of fragile X syndrome and autism. PLoS One 5:e9706","journal-title":"PLoS One"},{"key":"724_CR42","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.bbrc.2004.02.061","volume":"316","author":"F Takahashi-Yanaga","year":"2004","unstructured":"Takahashi-Yanaga F, Shiraishi F, Hirata M et al (2004) Glycogen synthase kinase-3beta is tyrosine-phosphorylated by MEK1 in human skin fibroblasts. Biochem Biophys Res Commun 316:411\u2013415","journal-title":"Biochem Biophys Res Commun"},{"key":"724_CR43","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/ajmg.1401","volume":"105","author":"TH Wassink","year":"2001","unstructured":"Wassink TH, Piven J, Vieland VJ et al (2001) Evidence supporting WNT2 as an autism susceptibility gene. Am J Med Genet 105:406\u2013413","journal-title":"Am J Med Genet"},{"key":"724_CR44","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/cercor\/13.6.599","volume":"13","author":"A Chenn","year":"2003","unstructured":"Chenn A, Walsh CA (2003) Increased neuronal production, enlarged forebrains and cytoarchitectural distortions in beta-catenin overexpressing transgenic mice. Cereb Cortex 13:599\u2013606","journal-title":"Cereb Cortex"},{"key":"724_CR45","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1517\/14728222.2010.528394","volume":"14","author":"KA Villagonzalo","year":"2010","unstructured":"Villagonzalo KA, Dodd S, Dean O et al (2010) Oxidative pathways as a drug target for the treatment of autism. Expert Opin Ther Targets 14:1301\u20131310","journal-title":"Expert Opin Ther Targets"},{"key":"724_CR46","doi-asserted-by":"crossref","first-page":"268","DOI":"10.5414\/CP201466","volume":"49","author":"S Ounjaijean","year":"2011","unstructured":"Ounjaijean S, Westermarck T, Partinen M et al (2011) Increase in non-transferrin bound iron and the oxidative stress status in epilepsy patients treated using valproic acid monotherapy. Int J Clin Pharmacol Ther 49:268\u2013276","journal-title":"Int J Clin Pharmacol Ther"},{"key":"724_CR47","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10571-009-9438-7","volume":"30","author":"B Zhang","year":"2010","unstructured":"Zhang B, Wang X, Nazarali AJ (2010) Ascorbic acid reverses valproic acid-induced inhibition of hoxa2 and maintains glutathione homeostasis in mouse embryos in culture. Cell Mol Neurobiol 30:137\u2013148","journal-title":"Cell Mol Neurobiol"},{"key":"724_CR48","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1124\/mol.111.072314","volume":"80","author":"EW Tung","year":"2011","unstructured":"Tung EW, Winn L (2011) Valproic acid increases formation of reactive oxygen species and induces apoptosis in postimplantation embryos: a role for oxidative stress in valproic acid-induced neural tube defects. Mol Pharmacol 80:979\u2013987","journal-title":"Mol Pharmacol"},{"key":"724_CR49","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s10803-006-0117-y","volume":"36","author":"GC Wagner","year":"2006","unstructured":"Wagner GC, Reuhl KR, Cheh M et al (2006) A new neurobehavioral model of autism in mice: pre- and postnatal exposure to sodium valproate. J Autism Dev Disord 36:779\u2013793","journal-title":"J Autism Dev Disord"},{"key":"724_CR50","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.neures.2006.10.018","volume":"57","author":"N Tsujino","year":"2007","unstructured":"Tsujino N, Nakatani Y, Seki Y et al (2007) Abnormality of circadian rhythm accompanied by an increase in frontal cortex serotonin in animal model of autism. Neurosci Res 57:289\u2013295","journal-title":"Neurosci Res"},{"key":"724_CR51","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.neulet.2009.12.054","volume":"470","author":"D Dufour-Rainfray","year":"2010","unstructured":"Dufour-Rainfray D, Vourc\u2019h P, Le GAM et al (2010) Behavior and serotonergic disorders in rats exposed prenatally to valproate: a model for autism. Neurosci Lett 470:55\u201359","journal-title":"Neurosci Lett"},{"key":"724_CR52","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/sj.npp.1301453","volume":"33","author":"K Markram","year":"2008","unstructured":"Markram K, Rinaldi T, La Mendola D et al (2008) Abnormal fear conditioning and amygdala processing in an animal model of autism. Neuropsychopharmacology 33:901\u2013912","journal-title":"Neuropsychopharmacology"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-012-0724-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-012-0724-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-012-0724-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,31]],"date-time":"2021-12-31T17:29:33Z","timestamp":1640971773000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-012-0724-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,29]]},"references-count":52,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["724"],"URL":"https:\/\/doi.org\/10.1007\/s11064-012-0724-2","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,29]]}}}